POS0538 THE IMPACT OF IMMUNOMODULATING TREATMENT ON THE SEROLOGICAL IMMUNOGENICITY FOLLOWING THREE DOSES OF COVID-19 VACCINE AND PERSISTENCE OF IMMUNOGENICITY OF TWO VACCINE DOSES IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES - A SWEDISH STUDY (COVID19-REUMA)

Frodlund M, Nived P, Chatzidionysiou K, Södergren A, Klingberg E, Hansson M, Pin E, Klareskog L, Kapetanovic MC

Ann Rheum Dis 82 (-) 533 [2023-06-00; online 2023-06-00]

DOI 10.1136/annrheumdis-2023-eular.1803

Crossref 10.1136/annrheumdis-2023-eular.1803